| human | Q5 |
| P496 | ORCID iD | 0000-0002-4061-4133 |
| P214 | VIAF ID | 52571676 |
| P10832 | WorldCat Entities ID | E39PBJyxgKFYr7C6by8J9J9xDq |
| P27 | country of citizenship | Denmark | Q35 |
| P69 | educated at | Leiden University | Q156598 |
| University of Copenhagen | Q186285 | ||
| P108 | employer | Capital Region of Denmark | Q26073 |
| P735 | given name | Stig | Q2003540 |
| Stig | Q2003540 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
| Q37332232 | A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q36477652 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q38768803 | AHRR (cg05575921) hypomethylation marks smoking behaviour, morbidity and mortality |
| Q64233831 | AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival |
| Q47653594 | AHRR hypomethylation, lung function, lung function decline, and respiratory symptoms |
| Q57307156 | Abstract 817: Mendelian randomization and mediation analysis of 5p15.33, telomere length and lung cancer risk |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q30779634 | Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q58352017 | Appraising the causal relevance of DNA methylation for risk of lung cancer |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
| Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q46173080 | Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q35664158 | Associations between first and second primary cancers: a population-based study |
| Q119213340 | Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q40055325 | Asthma, other atopic conditions and risk of infections in 105 519 general population never and ever smokers |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q51766715 | Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q93069507 | Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high-risk myelodysplastic syndrome |
| Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q102073628 | Burden of prediabetes, undiagnosed, and poorly or potentially sub-controlled diabetes: Lolland-Falster health study |
| Q40277494 | C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease |
| Q50554747 | CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis. |
| Q37048943 | CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
| Q43281078 | CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50,000 individuals |
| Q82709378 | CYP2C9 genotype does not affect risk of tobacco-related cancer in the general population |
| Q46638291 | Cancer patients should not be treated with statins. Reply |
| Q35653750 | Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population |
| Q99353311 | Causal Relationships between Body Mass Index, Smoking, and Lung Cancer: Univariable and Multivariable Mendelian Randomization |
| Q90899297 | Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q37368000 | Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms |
| Q50574525 | Common breast cancer risk alleles and risk assessment: a study on 35 441 individuals from the Danish general population. |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q43299072 | Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals |
| Q115209587 | Common variants in breast cancer risk loci predispose to distinct tumor subtypes |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q51365736 | Cytochrome P450 1B1 and 2C9 genotypes and risk of ischemic vascular disease, cancer, and chronic obstructive pulmonary disease. |
| Q37685729 | DNA mismatch repair gene MSH6 implicated in determining age at natural menopause |
| Q34806348 | Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer |
| Q44345261 | Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population |
| Q48358571 | Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population |
| Q35558075 | Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study |
| Q36213507 | Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study |
| Q122951834 | Epigenetic Regulation of Associates With Myocardial Infarction and Platelet Function |
| Q57250672 | Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk |
| Q99720321 | Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q58351991 | Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q36856343 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
| Q114182808 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
| Q64064541 | Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q59544908 | Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q36422109 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q34548284 | Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q29417050 | Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk |
| Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
| Q90438214 | Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q47736284 | Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population |
| Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
| Q38823212 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk |
| Q91176578 | Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma |
| Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q29417155 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array |
| Q36720814 | Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q58351997 | Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q41741900 | IgE and risk of cancer in 37 747 individuals from the general population |
| Q92480678 | Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility |
| Q92607964 | Incidental lymphopenia and mortality: a prospective cohort study |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q40906156 | Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study |
| Q80035778 | Increased risk of breast cancer associated with CHEK2*1100delC |
| Q46831159 | Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes |
| Q40747550 | Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q43926480 | Integrin beta3 Leu33Pro homozygosity and risk of cancer |
| Q40247065 | Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population |
| Q91528393 | Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q63352570 | Is high vitamin B12 status a cause of lung cancer? |
| Q57700847 | Is smoking heaviness causally associated with alcohol use? A Mendelian randomization study in four European cohorts |
| Q90258294 | JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing |
| Q36036299 | JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q47710019 | Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q38730359 | Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q52855805 | Long telomeres and cancer risk among 95 568 individuals from the general population. |
| Q46179048 | Long-term prostate-specific antigen velocity in improved classification of prostate cancer risk and mortality |
| Q94555037 | Loss-of-function polymorphism in IL6R reduces risk of JAK2V617F somatic mutation and myeloproliferative neoplasm: A Mendelian randomization study |
| Q38428639 | Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis |
| Q100393514 | Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q43776473 | Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer |
| Q58084817 | Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q54470367 | Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer. |
| Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q36614826 | No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q33778268 | Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study |
| Q41653273 | Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population |
| Q90348983 | Observational and genetic studies of short telomeres and Alzheimer's disease in 67,000 and 152,000 individuals: a Mendelian randomization study |
| Q40847064 | Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
| Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
| Q37307937 | Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium |
| Q44430361 | Peripheral blood leukocyte telomere length and mortality among 64,637 individuals from the general population |
| Q92440759 | Physical activity and risk of instant and 28-day case-fatality in myocardial infarction |
| Q44385923 | Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease |
| Q35611930 | Plasma testosterone in the general population, cancer prognosis and cancer risk: a prospective cohort study |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q114184065 | Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival |
| Q94562441 | Protein-altering germline mutations implicate novel genes related to lung cancer development |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q44258718 | Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q53771326 | Reply from Authors re: Andrew J. Vickers, Michael J. Pencina. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol 2013;64:394-6: prostate-specific antigen velocity: new unscreened cohort, na |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q39193926 | Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormone-receptor status |
| Q42217129 | Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. |
| Q53470715 | Risk of cancer by ATM missense mutations in the general population. |
| Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
| Q48949683 | Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study. |
| Q38836316 | Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases |
| Q36545934 | SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival |
| Q91453179 | Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study |
| Q29417074 | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q38292202 | Short Telomere Length and Ischemic Heart Disease: Observational and Genetic Studies in 290 022 Individuals |
| Q54278279 | Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals. |
| Q40206781 | Shorter leukocyte telomere length is associated with higher risk of infections: a prospective study of 75,309 individuals from the general population |
| Q92336085 | Smoking and Increased White and Red Blood Cells |
| Q92244700 | Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people |
| Q45920792 | Splice site mutations in mismatch repair genes and risk of cancer in the general population. |
| Q34645107 | Statin use and reduced cancer-related mortality |
| Q33671908 | TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals |
| Q48037084 | Telomere length and depression: prospective cohort study and Mendelian randomisation study in 67 306 individuals |
| Q35119841 | Telomere shortening unrelated to smoking, body weight, physical activity, and alcohol intake: 4,576 general population individuals with repeat measurements 10 years apart |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q34612649 | The JAK2 V617F somatic mutation, mortality and cancer risk in the general population |
| Q37578078 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q94581381 | Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q91158802 | Transcriptome-wide association study reveals candidate causal genes for lung cancer |
| Q36229441 | Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q91845898 | Two-fold risk of pneumonia and respiratory mortality in individuals with myeloproliferative neoplasm: A population-based cohort study |
| Q38202249 | Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study |
| Q109309676 | Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants |
| Q54191667 | YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies. |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.